v3.26.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Revenues $ 161 $ 106,207
Cost of revenues (763) (18,233)
Gross profit (loss) (602) 87,974
Operating expenses:    
Research and development (including amounts of related party of $228,951 and $246,260 for the three months ended March 31, 2026, and 2025, respectively) 1,689,860 1,724,084
Selling, general and administrative 593,185 1,526,761
Total operating expenses 2,283,045 3,250,845
Loss from operations (2,283,647) (3,162,871)
Non-operating (expenses) income, net:    
Interest expense (176,876) (180,445)
Other income, net 723 57,294
Total non-operating expenses, net (176,153) (123,151)
Net loss before income taxes (2,459,800) (3,286,022)
Provision for income taxes
Net loss $ (2,459,800) $ (3,286,022)
Net loss per common share - basic $ (0.41) $ (1.04)
Net loss per common share - diluted $ (0.41) $ (1.04)
Weighted-average shares used in computing net loss per common share-basic 6,031,585 3,172,611
Weighted-average shares used in computing net loss per common share-diluted 6,031,585 3,172,611